All News #Library
Rare Diseases
Renaissance Pharma Secures FDA Fast Track For Daretabart
14 Apr 2026 //
GLOBENEWSWIRE
Essential Pharma Acquires Ventavis to Bolster Pulmonary Portfolio
17 Feb 2026 //
GLOBENEWSWIRE
Essential Pharma Signs Strategic Agreement with AGC Biologics
11 Jun 2024 //
CONTRACT PHARMA

Market Place
Sourcing Support